Conmed Corp. - Ordinary Shares

97.40-3.11-3.09%Vol 287.35K1Y Perf -20.44%
Aug 9th, 2022 16:00 DELAYED
BID96.22 ASK97.84
Open99.98 Previous Close100.51
Pre-Market- After-Market97.11
 - -  -0.29 -0.30%
Target Price
144.00 
Analyst Rating
Moderate Buy 1.83
Potential %
47.84 
Finscreener Ranking
     39.98
Insiders Trans % 3/6/12 mo.
-100/-100/-100 
Value Ranking
+     37.15
Insiders Value % 3/6/12 mo.
-100/-100/-100 
Growth Ranking
★★★     52.40
Insiders Shares Cnt. % 3/6/12 mo.
-100/-100/-100 
Income Ranking
+     27.07
Price Range Ratio 52W %
14.14 
Earnings Rating
Sell
Market Cap2.97B 
Earnings Date
27th Jul 2022
Alpha0.00 Standard Deviation0.10
Beta1.56 

Today's Price Range

96.84100.99

52W Range

87.24159.11

5 Year PE Ratio Range

25.30530.40

Summary:

Neutral

Technical Indicators: Neutral
Moving Averages: Neutral
Performance
1 Week
2.08%
1 Month
5.36%
3 Months
-7.44%
6 Months
-29.07%
1 Year
-20.44%
3 Years
6.05%
5 Years
102.52%
10 Years
296.40%

TickerPriceChg.Chg.%
CNMD97.40-3.1100-3.09
AAPL164.920.05000.03
GOOG117.50-0.6400-0.54
MSFT282.301.98000.71
XOM90.591.64001.84
WFC43.400.21000.49
JNJ170.18-0.0200-0.01
FB196.640.99000.51
GE74.93-0.2500-0.33
JPM115.381.03000.90
 
ProfitabilityValueIndustryS&P 500US Markets
56.40
10.90
17.70
4.80
7.04
RevenueValueIndustryS&P 500US Markets
765.13M
25.91
3.46
4.94
DividendsValueIndustryS&P 500US Markets
0.84
0.80
0.00
0.00
Payout ratio44.00
Earnings HistoryEstimateReportedSurprise %
Q02 20220.760.760.00
Q01 20220.620.7012.90
Q04 20211.051.071.90
Q03 20210.770.803.90
Q02 20210.620.7114.52
Q01 20210.430.6346.51
Q04 20200.780.847.69
Q03 20200.250.88252.00
Earnings Per EndEstimateRevision %Trend
6/2022 QR0.76-15.56Negative
9/2022 QR0.940.00-
12/2022 FY3.51-5.14Negative
12/2023 FY4.01-6.09Negative
Next Report Date-
Estimated EPS Next Report0.76
Estimates Count6
EPS Growth Next 5 Years %12.30
Volume Overview
Volume287.35K
Shares Outstanding30.47K
Shares Float21.42M
Trades Count6.24K
Dollar Volume28.23M
Avg. Volume406.95K
Avg. Weekly Volume372.07K
Avg. Monthly Volume364.42K
Avg. Quarterly Volume484.37K

Conmed Corp. - Ordinary Shares (NASDAQ: CNMD) stock closed at 100.51 per share at the end of the most recent trading day (a 3.61% change compared to the prior day closing price) with a volume of 273.98K shares and market capitalization of 2.97B. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 3400 people. Conmed Corp. - Ordinary Shares CEO is Curt R. Hartman.

The one-year performance of Conmed Corp. - Ordinary Shares stock is -20.44%, while year-to-date (YTD) performance is -29.1%. CNMD stock has a five-year performance of 102.52%. Its 52-week range is between 87.24 and 159.11, which gives CNMD stock a 52-week price range ratio of 14.14%

Conmed Corp. - Ordinary Shares currently has a PE ratio of 45.80, a price-to-book (PB) ratio of 3.59, a price-to-sale (PS) ratio of 3.68, a price to cashflow ratio of 35.50, a PEG ratio of 2.32, a ROA of 3.94%, a ROC of 6.24% and a ROE of 9.18%. The company’s profit margin is 7.04%, its EBITDA margin is 17.70%, and its revenue ttm is $765.12 Million , which makes it $25.91 revenue per share.

Of the last four earnings reports from Conmed Corp. - Ordinary Shares, there were 3 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $0.76 for the next earnings report. Conmed Corp. - Ordinary Shares’s next earnings report date is -.

The consensus rating of Wall Street analysts for Conmed Corp. - Ordinary Shares is Moderate Buy (1.83), with a target price of $144, which is +47.84% compared to the current price. The earnings rating for Conmed Corp. - Ordinary Shares stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

Conmed Corp. - Ordinary Shares has a dividend yield of 0.84% with a dividend per share of $0.80 and a payout ratio of 44.00%.

Conmed Corp. - Ordinary Shares has a Neutral technical analysis rating based on Technical Indicators (ADX : 9.11, ATR14 : 3.41, CCI20 : 32.35, Chaikin Money Flow : 0.16, MACD : -0.12, Money Flow Index : 50.97, ROC : -1.61, RSI : 52.16, STOCH (14,3) : 54.60, STOCH RSI : 0.74, UO : 49.45, Williams %R : -45.40), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of Conmed Corp. - Ordinary Shares in the last 12-months were: Barbara J Schwarzentraub (Option Excercise at a value of $0), Brent Lalomia (Option Excercise at a value of $0), Brian P. Concannon (Option Excercise at a value of $518 729), Brian P. Concannon (Sold 12 984 shares of value $1 762 324 ), Charles M. Farkas (Option Excercise at a value of $0), Curt R. Hartman (Sold 0 shares of value $-3 976 205 ), Curt R. Hartman (Sold 5 000 shares of value $664 540 ), Daniel S. Jonas (Sold 0 shares of value $-2 874 836 ), Daniel S. Jonas (Sold 33 957 shares of value $4 850 850 ), David M. Bronson (Option Excercise at a value of $0), Jaclyn Peterson (Option Excercise at a value of $0), Jerome J Lande (Option Excercise at a value of $0), Jerome J Lande (Sold 7 521 shares of value $870 493 ), John E. Kennedy (Option Excercise at a value of $1 830 003), John E. Kennedy (Sold 32 272 shares of value $4 602 438 ), John L. Workman (Option Excercise at a value of $0), Johonna Pelletier (Sold 0 shares of value $-674 414 ), Johonna Pelletier (Sold 9 197 shares of value $1 421 102 ), LaVerne Council (Option Excercise at a value of $0), Mark E. Tryniski (Option Excercise at a value of $855 506), Mark E. Tryniski (Sold 12 420 shares of value $1 943 745 ), Martha Goldberg Aronson (Option Excercise at a value of $0), Patrick J. Beyer (Option Excercise at a value of $4 805 721), Patrick J. Beyer (Sold 42 729 shares of value $6 270 747 ), Stanley W. Peters (Sold 0 shares of value $-1 001 269 ), Stanley W. Peters (Sold 24 700 shares of value $3 744 890 ), Todd W. Garner (Option Excercise at a value of $425 124), Todd W. Garner (Sold 13 734 shares of value $1 693 093 )

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
3 (50.00 %)
4 (57.14 %)
5 (62.50 %)
Moderate Buy
1 (16.67 %)
1 (14.29 %)
1 (12.50 %)
Hold
2 (33.33 %)
2 (28.57 %)
2 (25.00 %)
Moderate Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Strong Sell
0 (0.00 %)
0 (0.00 %)
0 (0.00 %)
Summary RatingModerate Buy
1.83
Moderate Buy
1.71
Moderate Buy
1.63

Conmed Corp. - Ordinary Shares

Conmed Corp is a Utica, New York-based medical equipment company that focuses on sports medicine procedures and general surgery. The firm currently reports through two reporting units, orthopedic surgery (52% of 2018 sales) and general surgery (48%). From a geographic perspective the firm is U.S. centric, with domestic sales accounting for 52% of revenue, EMEA accounting for 19%, APAC at 17%, and the non-U.S. Americas region driving the remaining 12%.

CEO: Curt R. Hartman

Telephone: +1 727 392-6464

Address: 11311 Concept Boulevard, Largo 33773, FL, US

Number of employees: 3 400

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

46%54%

Bearish Bullish

50%50%

Bearish Bullish

49%51%

TipRanks News for CNMD


News

Stocktwits